×
We couldn’t find any recent recommendations for this company (matched by symbol or BSE code). Please check back later.
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| Fabino Enterprises Ltd | NA | NA | NA | NA | 5.09 | 84.8 |
| Triochem Products Ltd | 2.21 | -1.32 | NA | -5.38 | 0 | |
| Gujarat Terce Laboratories Ltd | 124.20 | 7.61 | 122.94 | 0.95 | 42.8 | |
| Roopa Industries Ltd | 335.44 | 7.69 | 335.43 | 0.98 | 41.8 | 20.5 |
| KMS Medisurgi Ltd | NA | NA | NA | NA | 41.8 | 94.9 |
Gujarat Terce Laboratories Ltd, with Security Code 524314, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Sales | 13.0 | 12.2 | 11.9 | 13.3 | 12.7 | 12.3 | 12.9 | 12.3 |
| Expenses | 12.2 | 11.2 | 11.8 | 11.6 | 11.6 | 11.2 | 11.0 | 11.2 |
| Operating Profit | 0.8 | 1.0 | 0.1 | 1.7 | 1.1 | 1.1 | 1.9 | 1.1 |
| OPM % | 6.51% | 8.22% | 0.65% | 12.49% | 8.6% | 8.89% | 14.61% | 9.26% |
| Other Income | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| Interest | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 |
| Depreciation | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| Profit before tax | 0.7 | 0.8 | -0.1 | 1.5 | 1.0 | 1.0 | 1.8 | 1.1 |
| Tax % | 0% | -35.7% | 11.6% | -2.1% | 3.1% | -444.2% | -21.3% | -32.5% |
| Net Profit | 0.7 | 0.5 | -0.1 | 1.5 | 1.0 | -3.4 | 1.4 | 0.8 |
| EPS in Rs | 0.91 | 0.73 | -0.1 | 2 | 1.36 | -4.35 | 0 | 0 |
| Metrics | Sep 2019 | Dec 2019 |
|---|---|---|
| Sales | 11.1 | 10.1 |
| Expenses | 9.3 | 9.7 |
| Operating Profit | 1.8 | 0.5 |
| OPM % | 16.51% | 4.52% |
| Other Income | 0.0 | 0.0 |
| Interest | 0.1 | 0.0 |
| Depreciation | 0.1 | 0.1 |
| Profit before tax | 1.7 | 0.4 |
| Tax % | 0% | 0% |
| Net Profit | 1.7 | 0.4 |
| EPS in Rs | 0.23 | 0.5 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 9% |
| 3 Years: | 24% |
| TTM: | 3% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | -11% |
| 3 Years: | 28% |
| TTM: | 502% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 19% |
| 5 Years: | 42% |
| 3 Years: | 13% |
| 1 Year: | 6% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | -33% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | -1000% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 19% |
| 5 Years: | 42% |
| 3 Years: | 13% |
| 1 Year: | 6% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| News Date ▲▼ | Headline ▲▼ | Issuer Entity ▲▼ | Issuer Type ▲▼ | Order Size ▲▼ | Time Period ▲▼ | |
|---|---|---|---|---|---|---|
| Loading company updates… | ||||||
We couldn’t find any filings or updates in the Company News collection for this BSE code.
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|